[Effects of 3 doses of maprotiline (25, 50 and 75 mg) on alertness and memory in healthy volunteers]. 1989

D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech

The effects on psychomotor and mnesic performance of acute oral doses of maprotiline (25, 50 and 75 mg) were evaluated in twelve healthy men in a placebo-controlled double blind study. A battery of tests was performed comprising: objective measures (critical flicker frequency, choice reaction time, memory tasks) and self rating evaluation (visual analogue scales). Tests session took place 15 hours after each treatment. Plasma concentrations of maprotiline were determined. Compared with placebo, maprotiline induced psychomotor impairment on both objective and subjective assessment in a dose related manner. No significant difference between maprotiline and placebo on memory test could be evidenced.

UI MeSH Term Description Entries
D008297 Male Males
D008376 Maprotiline A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use. Ba-34,276,Deprilept,Dibencycladine,Ludiomil,Maprolu,Maprotilin,Maprotilin Holsten,Maprotilin-TEVA,Maprotilin-neuraxpharm,Maprotilin-ratiopharm,Maprotiline Hydrochloride,Maprotiline Mesylate,Mirpan,N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine,Novo-Maprotiline,Psymion,maprotilin von ct,Ba34,276,Hydrochloride, Maprotiline,Maprotilin TEVA,Maprotilin neuraxpharm,Maprotilin ratiopharm,Mesylate, Maprotiline,Novo Maprotiline
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000873 Anthracenes A group of compounds with three aromatic rings joined in linear arrangement.
D001143 Arousal Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system. Vigilance, Cortical,Arousals,Cortical Vigilance

Related Publications

D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
October 1987, Pharmaceutical research,
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
January 1991, Psychopharmacology,
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
June 2000, Journal of psychopharmacology (Oxford, England),
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
January 2003, International journal of pharmaceutical compounding,
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
January 1983, Archiv fur Psychiatrie und Nervenkrankheiten,
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
November 2011, Journal of psychopharmacology (Oxford, England),
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
May 2014, International journal of clinical pharmacology and therapeutics,
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
June 2011, Journal of clinical psychopharmacology,
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
September 2009, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
D Warot, and P Danjou, and L Lacomblez, and B Diquet, and A J Puech
January 1988, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!